Skip to main content

Phreesia, Inc.

corporate_fare Company Profile

Phreesia, Inc.

PHR·NYSE·Trade & Services·CIK 0001412408

Phreesia, Inc. was founded in 2005 and provides an integrated software, payments, and engagement platform for healthcare delivery. The company's platform is designed to address challenges in access to care, affordability of care, and patient health outcomes. It is integrated into provider workflows and patient interactions, helping healthcare organizations activate patients, streamline administrative processes, and improve financial performance. Phreesia serves ambulatory practices, health systems, hospitals, life sciences companies, government entities, patient advocacy, public interest, and not-for-profit organizations. Its solutions support the patient journey from care discovery and scheduling through intake, payment, and post-visit follow-up. In fiscal year 2026, the platform facilitated approximately 180 million patient visits, representing approximately one in six ambulatory patient visits in the United States. In fiscal year 2026, Phreesia acquired AccessOne Parent Holdings, Inc. (AccessOne), expanding its addressable market for healthcare payments and offering healthcare providers a payment card that accelerates cash flow. Phreesia generates revenue from three streams: subscription and related services; payment solutions, which include payment processing fees and financing fees; and Network Solutions, which allows life sciences companies and other organizations to deliver engagement to patients and providers using Phreesia's solutions. Revenue is primarily derived from recurring subscription fees and re-occurring payment processing and financing fees. Subscription and related services revenue is consistent throughout the fiscal year, while payment solutions revenue is typically higher during the first two to three months of the calendar year due to patient deductibles resetting.

Phreesia, Inc. (NYSE:PHR) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 23 items for PHR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-03, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for PHR spans 10-Q, 8-K, DEFA14A, DEF 14A.

Recent high-impact activity:

  • Phreesia Q2 10-Q: $1.9M Net Income, Data Breach Settlement, and CEO Trading Plan
  • Phreesia Guides FY27 Revenue to $510M-$520M, Above Consensus
  • Phreesia Shares Plunge 27% on Outlook Cut and New Lawsuit Despite Q1 Revenue Growth
  • Phreesia Reports Q1 2027 Revenue of $130.9M, EPS of $0.05, Returns to Profitability
  • Phreesia Returns to GAAP Profitability with Strong Q1 Results, Bolstered by Refinancing, but Faces New Securities Lawsuit

Financial Snapshot

Fiscal year ended January 31, 2026
Revenue
$480.59M
Net Income
$2.31M
Diluted EPS
$0.04
Op. Cash Flow
$78.81M
Free Cash Flow
$67.71M
Operating Income
-$6.61M
Cash & Equivalents
$73.83M
Total Debt
$2.66M
Debt / Equity
0.01×
Net Margin
0.5%
Shares Outstanding
59.74M sh
Source: 10-K · filed 2026-03-31 · accession 0001412408-26-000079

Short Interest & Short Volume

4.26 days to cover

FINRA reported short interest of 3,021,990 shares in PHR as of the October 30, 2026 settlement, a 1.9% decrease from the prior period — about 4.3 days to cover at its recent average daily volume. On November 20, 2026, 33.5% of PHR volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)3,021,990 shares as of October 30, 2026
Change vs prior period▼ 1.9%
Days to cover4.26 at avg daily volume of 709,614
Daily short volume (FINRA facilities)33.5% of 526,289 shares on November 20, 2026
5-day average short volume49.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for PHR, detected from its recent SEC filings.

1 shelf registration

New Shelf Registration Filed · Indeterminate Amount Registered

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with P →
$11.19 -1.93% today
52-week range · as of 2026-09-03 $7.77 – $31.38
Market cap
$708.23M
Volume
1.2M (1.7× avg)
3-mo avg 677.9K
Live data · 2026-11-22 05:18 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed PHR - Latest Insights

PHR
Sep 03, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $10.85
Real-time Price: $11.19 info
Change: +$0.340 (+3%) info
Market Cap: $708.229M info
PHR
Sep 02, 2026, 4:06 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $11.65
Real-time Price: $11.19 info
Change: -$0.460 (-4%) info
Market Cap: $708.229M info
PHR
May 29, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $9.51
Real-time Price: $11.19 info
Change: +$1.68 (+18%) info
Market Cap: $708.229M info
PHR
May 28, 2026, 4:11 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $9.48
Real-time Price: $11.19 info
Change: +$1.71 (+18%) info
Market Cap: $708.229M info
PHR
May 28, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $9.45
Real-time Price: $11.19 info
Change: +$1.74 (+18%) info
Market Cap: $708.229M info
PHR
May 28, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $10.63
Real-time Price: $11.19 info
Change: +$0.564 (+5%) info
Market Cap: $708.229M info
PHR
May 27, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $9.90
Real-time Price: $11.19 info
Change: +$1.29 (+13%) info
Market Cap: $708.229M info
PHR
May 27, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.13
Real-time Price: $11.19 info
Change: +$2.06 (+23%) info
Market Cap: $708.229M info
PHR
May 14, 2026, 4:00 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $8.77
Real-time Price: $11.19 info
Change: +$2.42 (+28%) info
Market Cap: $708.229M info
PHR
May 14, 2026, 3:59 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $8.77
Real-time Price: $11.19 info
Change: +$2.42 (+28%) info
Market Cap: $708.229M info
PHR
May 11, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $9.57
Real-time Price: $11.19 info
Change: +$1.62 (+17%) info
Market Cap: $708.229M info
PHR
May 04, 2026, 5:23 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $9.67
Real-time Price: $11.19 info
Change: +$1.52 (+16%) info
Market Cap: $708.229M info
PHR
May 04, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.67
Real-time Price: $11.19 info
Change: +$1.52 (+16%) info
Market Cap: $708.229M info
PHR
Apr 02, 2026, 6:45 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $8.38
Real-time Price: $11.19 info
Change: +$2.81 (+34%) info
Market Cap: $708.229M info
PHR
Apr 02, 2026, 6:41 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $8.35
Real-time Price: $11.19 info
Change: +$2.84 (+34%) info
Market Cap: $708.229M info
PHR
Mar 30, 2026, 5:29 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.91
Real-time Price: $11.19 info
Change: +$2.28 (+26%) info
Market Cap: $708.229M info
PHR
Mar 30, 2026, 4:03 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $11.20
Real-time Price: $11.19 info
Change: -$0.0100 (-0.09%) info
Market Cap: $708.229M info
PHR
Mar 19, 2026, 6:52 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $11.82
Real-time Price: $11.19 info
Change: -$0.630 (-5%) info
Market Cap: $708.229M info
PHR
Mar 19, 2026, 6:46 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $11.82
Real-time Price: $11.19 info
Change: -$0.630 (-5%) info
Market Cap: $708.229M info
PHR
Mar 16, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.99
Real-time Price: $11.19 info
Change: +$0.200 (+2%) info
Market Cap: $708.229M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets